Association of Gene Expression Involving Innate Immunity and Genetic Variation in Interleukin 28B With Antiviral Response

Yasuhiro Asahina(Tokyo Medical and Dental University), Namiki Izumi(Musashino Red Cross Hospital)

Hepatology

September 1, 2011

10.1002/hep.24623

Cited by 58

Related Papers

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

|Gut|2019|720

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis

|Gut|2021|96

No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations

|BMC Medical Genetics|2012|41

Low liver fat in non‐alcoholic steatohepatitis‐related significant fibrosis and cirrhosis is associated with <scp>hepatocellular carcinoma</scp>, decompensation and mortality

|Alimentary Pharmacology & Therapeutics|2023|24

Quantitative measurements of M2BPGi depend on liver fibrosis and inflammation

|Journal of Gastroenterology|2024|23